Tahereh Gol-Mohammadian
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing.
Journal: Molecular therapy. Oncology
Published: March 09, 2025
Gene therapy in pediatrics - Clinical studies and approved drugs (as of 2023).
Journal: Life sciences
Published: January 19, 2024
CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells.
Journal: International journal of molecular sciences
Published: September 29, 2023
Accelerated generation of gene-engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9.
Journal: Biotechnology journal
Published: September 22, 2023
Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.
Journal: International journal of molecular sciences
Published: September 23, 2022
CRISPR medicine for blood disorders: Progress and challenges in delivery.
Journal: Frontiers in genome editing
Published: September 05, 2022
Depletion of Akt1 and Akt2 Impairs the Repair of Radiation-Induced DNA Double Strand Breaks via Homologous Recombination.
Journal: International journal of molecular sciences
Published: October 10, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026